B Cell Receptor Signaling Pathway Mutation as Prognosis Predictor of Immune Checkpoint Inhibitors in Lung Adenocarcinoma by Bioinformatic Analysis

B Cell Receptor Signaling Pathway Mutation as Prognosis Predictor of Immune Checkpoint Inhibitors in Lung Adenocarcinoma by Bioinformatic Analysis

Anqi Lin,1,* Jianbo Fang,1,* Quan Cheng,2,3 Zaoqu Liu,4 Peng Luo,1 Jian Zhang1 1Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, People’s Republic of China; 2Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha,...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs: Lin A, Fang J, Cheng Q, Liu Z, Luo P, Zhang J
Formaat: Artikel
Taal:English
Gepubliceerd in: Dove Medical Press 2022-09-01
Reeks:Journal of Inflammation Research
Onderwerpen:
non-small cell lung cancer
b cell receptor
immune checkpoint inhibitor
biomarker
microenvironment.
Online toegang:https://www.dovepress.com/b-cell-receptor-signaling-pathway-mutation-as-prognosis-predictor-of-i-peer-reviewed-fulltext-article-JIR

Internet

https://www.dovepress.com/b-cell-receptor-signaling-pathway-mutation-as-prognosis-predictor-of-i-peer-reviewed-fulltext-article-JIR

Gelijkaardige items